Literature DB >> 23751244

Visual contrast sensitivity in major depressive disorder.

Johnson Fam1, A John Rush, Benjamin Haaland, Sylvaine Barbier, Chi Luu.   

Abstract

OBJECTIVE: Through the eyes of those depressed, the world may appear dull and gray. Visual contrast sensitivity has recently been reported to be lower in depressed patients compared to healthy controls. We aimed to examine the consistency of this finding and to explore the underlying retinal electrophysiology.
METHODS: Twenty subjects with major depressive disorder and 20 matched healthy controls were studied. Pattern electroretinogram (PERG) and subjective visual contrast test were used to assess visual contrast sensitivity. Full-field electroretinography (ffERG) was additionally used to assess retinal neurophysiology. Depression was diagnosed based on the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV) and depression severity was measured using standard psychometric scales.
RESULTS: Visual contrast sensitivity was significantly lower in depressed patients compared to controls based on the Landolt C visual contrast test, but no difference was found between groups using PERG and ffERG. Greater severity of depressive symptoms correlated (r=0.49, p=0.001) with poorer visual contrast sensitivity.
CONCLUSIONS: Depressed subjects had reduced visual contrast discrimination performance, but this finding could not be consistently determined using PERG. The neurobiological link between major depressive disorder and visual contrast sensitivity warrants further investigation.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2013        PMID: 23751244     DOI: 10.1016/j.jpsychores.2013.03.008

Source DB:  PubMed          Journal:  J Psychosom Res        ISSN: 0022-3999            Impact factor:   3.006


  10 in total

Review 1.  Visual Impairment and Mental Health: Unmet Needs and Treatment Options.

Authors:  Docia L Demmin; Steven M Silverstein
Journal:  Clin Ophthalmol       Date:  2020-12-03

2.  Neuroanatomical substrates underlying contrast sensitivity.

Authors:  Ying Yang; Yajun Wang; Cun Zhang; Jiajia Zhu; Yongqiang Yu
Journal:  Quant Imaging Med Surg       Date:  2019-03

Review 3.  A Possible Link between Anxiety and Schizophrenia and a Possible Role of Anhedonia.

Authors:  Luigi Grillo
Journal:  Schizophr Res Treatment       Date:  2018-01-17

4.  Abnormal functional connectivity of the amygdala is associated with depressive symptoms in patients with multiple system atrophy.

Authors:  Bin Zhao; Hu Liu; Huanhuan Li; Xiuli Shang
Journal:  Neuropsychiatr Dis Treat       Date:  2018-11-15       Impact factor: 2.570

5.  Differential and spatial expression meta-analysis of genes identified in genome-wide association studies of depression.

Authors:  Wennie Wu; Derek Howard; Etienne Sibille; Leon French
Journal:  Transl Psychiatry       Date:  2021-01-04       Impact factor: 6.222

6.  Reduced visual contrast suppression during major depressive episodes.

Authors:  Viljami Salmela; Lumikukka Socada; John Söderholm; Roope Heikkilä; Jari Lahti; Jesper Ekelund; Erkki Isometsä
Journal:  J Psychiatry Neurosci       Date:  2021-03-11       Impact factor: 6.186

7.  Remote Assessment of Depression Using Digital Biomarkers From Cognitive Tasks.

Authors:  Regan L Mandryk; Max V Birk; Sarah Vedress; Katelyn Wiley; Elizabeth Reid; Phaedra Berger; Julian Frommel
Journal:  Front Psychol       Date:  2021-12-15

8.  The impact of image degradation and temporal dynamics on sustained attention.

Authors:  Julia M Brau; Alexander Sugarman; David Rothlein; Joseph DeGutis; Michael Esterman; Francesca C Fortenbaugh
Journal:  J Vis       Date:  2022-03-02       Impact factor: 2.240

9.  High level of pattern glare in major depressive disorder.

Authors:  Xiongwei Qi; Huanhuan Fan; Xiao Yang; Yayun Chen; Wei Deng; Wanjun Guo; Qiang Wang; Eric Chen; Tao Li; Xiaohong Ma
Journal:  BMC Psychiatry       Date:  2019-12-21       Impact factor: 3.630

10.  Altered Visual Cortical Excitability Is Associated With Psychopathological Symptoms in Major Depressive Disorder.

Authors:  Hongheng Du; Xue Shen; Xiaoyan Du; Libo Zhao; Wenjun Zhou
Journal:  Front Psychiatry       Date:  2022-03-07       Impact factor: 4.157

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.